Key Findings
The United States biopsy devices market is projected to grow at a CAGR of 7.79% over the forecast years. While the base year considered for the market is 2023, the forecast period is from 2024 to 2032. The market growth is boosted by various factors, comprising the rising prevalence of cancer, increasing demand for minimally invasive surgeries, and a surge in the number of hospitals and diagnostic centers.

Market Insights
The elevation in the United States biopsy devices market is powered by increased healthcare spending, indicating a commitment to investing in advanced medical technologies, particularly biopsy devices. This financial support is improving accessibility to advanced biopsy solutions, leading to enhanced diagnostic capabilities and better healthcare outcomes nationwide. A preeminent trend shaping the market is the shift towards preventive healthcare, aligning with the national focus on early detection and disease prevention.
Biopsy devices are vital in this preventive approach, facilitating timely identification and intervention. The emphasis on preventive healthcare positions biopsy devices as essential tools in advancing public health initiatives and reducing the overall burden of diseases in the United States. The market’s momentum is further fueled by expanding applications across medical specialties. Consequently, these factors are expected to foster the market’s growth in the United States during the forecast period.

Competitive Insights
Some of the major companies in the United States biopsy devices market include Argon Medical Devices, Cardinal Health, Boston Scientific, Hologic Inc, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments